News Agency
Men's Weekly

Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model

  • Written by Media Outreach

ABX464 is the only drug candidate with a potential triple action for COVID-19 treatment: antiviral, anti-inflammatory and tissue repair

 

  • ABX464, as assessed by RTqPCR, inhibits in vitro viral replication of SARS-CoV-2 (COVID-19)
  • Simultaneously, Abivax receives ANSM and CPP clearance[1] to test ABX464 as promising COVID-19 therapeutic candidate...

Read more: Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory...

Defence Recruitment: Building Australia’s Future Security Workforce

Australia’s defence sector is one of the nation’s most vital and rapidly evolving industries, offering stable and rewarding careers for individuals committed to protecting national interests. With the growing need for advanced technologies, cybersecurity, and global defence partnerships, opportunities in defence... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion